why choose us

300×250 Ad Slot

Research Article: Autoantibody profiling of patients with immune checkpoint inhibitor-associated myocarditis: a pilot study

Date Published: 2024-09-11

Abstract:
Background: Immune checkpoint inhibitor (ICI)-associated myocarditis is a rare, but potentially fatal, immune-related adverse event. Hence, identifying biomarkers is critical for selecting and managing patients receiving ICI treatment. Serum autoantibodies (AAbs) in patients with ICI myocarditis may serve as potential biomarkers for predicting, diagnosing, and prognosing ICI myocarditis. We conducted a pilot study using a human proteome microarray with approximately 17,000 unique full-length human proteins to investigate AAbs associated with ICI myocarditis.

No summary available.

300×250 Ad Slot